Here are three stocks that could potentially see nice offers vs. current prices if acquired.
Collegium Pharmaceutical should benefit greatly from its pending purchase of my stock pick for this year, BioDelivery Sciences International.
Australia's largest casino operator moves into final talks with Blackstone, and the board encourages investors to approve deal.
A chaotic news cycle has led to an equally wild swing in the share price of both names in the past week.
PTON reported earnings Tuesday morning, and there's no way to sugarcoat the revised full year guidance.
The athletic apparel maker's chart indicates its run could be over as it flashes bearish signals; meanwhile, it looks like Peloton may have put in a bottom.
I had actually worried a bit that Arm was going to take Jensen Huang's eye off of the ball. That worry can now be put to bed.
The PlayStation maker likely will introduce a subscription service later this year, hence the planned buyout of "Destiny" developer Bungie.
Let's see what the charts can tell us.
I always thought Kohl's was for sale, I just always thought it would be Amazon.